The acellular pertussis vaccine includes selected antigens like pertussis toxin, filamentous hemagglutinin, and pertactin. These are chosen for their ability to invoke a protective immune response without inducing the side effects often seen with whole-cell vaccines. The purification process ensures that unnecessary components are removed, which reduces the likelihood of toxicity and enhances the vaccine's safety profile.
